SMSN 964.0 0.2079% TYT 2786.5 4.8542% SMSD 806.0 -0.9828% SMSN 962.0 -1.1305% RIGD 63.4 5.6667% RIGD 60.0 -1.1532% SHEL 2458.0 -0.2435% AZN 10526.0 1.2115% BHP 1798.0 -0.663% HSBA 833.7 -0.036% ULVR 4699.0 0.2988% CYPC 40.6 0.0% RIO 4525.0 -0.5495% LLPC 1.548 -99.0% DGED 110.9983 0.7061% BP 362.0 -0.6722% SBID 95.4 2.2508% DGE 2070.0 0.2421% GSK 1409.0 1.4399% REL 3960.0 -1.0742%
SMSN 964.0 0.2079% TYT 2786.5 4.8542% SMSD 806.0 -0.9828% SMSN 962.0 -1.1305% RIGD 63.4 5.6667% RIGD 60.0 -1.1532% SHEL 2458.0 -0.2435% AZN 10526.0 1.2115% BHP 1798.0 -0.663% HSBA 833.7 -0.036% ULVR 4699.0 0.2988% CYPC 40.6 0.0% RIO 4525.0 -0.5495% LLPC 1.548 -99.0% DGED 110.9983 0.7061% BP 362.0 -0.6722% SBID 95.4 2.2508% DGE 2070.0 0.2421% GSK 1409.0 1.4399% REL 3960.0 -1.0742%

Markets Rally Amid AI Optimism, UK Rate Cut Speculation, and Global Economic Uncertainty:

By: Team Kalkine | Feb 06, 2025 | Read Time : 10 Mins
Markets Rally Amid AI Optimism, UK Rate Cut Speculation, and Global Economic Uncertainty:

Image Source : Krish Capital Pty Ltd

Index Update: The FTSE 100 index, a key benchmark index for the London stock exchange, went up around 1.51% on 06 February 2025.  

Macro Update:  The Bank of England is expected to cut interest rates for the third time since 2020 as it navigates a sluggish economy and persistent inflationary pressures. Economic growth has remained weak since mid-2024, weighed down by concerns over Finance Minister Rachel Reeves' tax hikes for employers, a potential global trade war led by U.S. President Donald Trump, and rising costs. Meanwhile, UK markets saw a rebound, with the FTSE 100 gaining 0.6% and the mid-cap FTSE 250 rising 0.5%, supported by strong performances in key sectors. Pharmaceutical giant GSK surged 7.6% after announcing a £2 billion share buyback and raising its long-term sales target to nearly $50 billion, while gold miners jumped 3.6% as gold prices hit record highs. Fresnillo climbed 5.8% after being named J.P. Morgan’s “top pick. 

Top Market Movers: Among top gainers on FTSE 100 index, Anglo American PLC (LSE: AAL) witnessed a rise of 6.65% followed by AstraZeneca PLC (LSE: AZN) which gained around 5.68%. 

Commodity Update: The U.S. dollar fell to an eight-week low against the yen and hovered near a one-month low against the pound as investor fears about a global trade war subsided. Japan's yen gained momentum, supported by rising expectations of further interest rate hikes by the Bank of Japan following strong wage data and a central bank official’s comment. In commodities, gold dropped 0.19% to $2,888.20, silver fell 0.61% to $32.77, while copper rose 0.75% to $9,335.20. Brent crude rose 0.19% to $74.55, recovering from a previous sell-off after Saudi Arabia raised March oil prices significantly. Investors await U.S. Non-Farm Payroll data for clearer insights on future rate decision. 

Our Stance: U.S. stock markets closed higher on Wednesday, rebounding from earlier declines as investors remained optimistic about potential interest rate cuts despite disappointing earnings from Alphabet. The Google parent dropped 7.3% after reporting slower cloud revenue growth and announcing a $75 billion investment in AI, raising concerns over profitability. Meanwhile, President Trump’s proposal for the U.S. to take control of Gaza and relocate Palestinians faced widespread global condemnation, with strong rebukes from Germany, China, Saudi Arabia, and Russia, warning it could fuel further instability and conflict. President Trump's threats of new tariffs on foreign goods have already contributed to market volatility this year. While investor confidence in AI remains strong, concerns over geopolitical tensions and economic policies continue to weigh on global market sentiment. 

FTSE 100 

The FTSE 100 finished at 8,623.29 on Wednesday, rising by 0.61%, and formed a bullish candlestick pattern, signalling positive market sentiment. The index remains above its 21-period Simple Moving Average (SMA), suggesting a favourable short-term outlook. Furthermore, the 50-period SMA provides solid support, reinforcing the potential for continued upward momentum. With the Relative Strength Index (RSI) at 65.25, the index shows healthy bullish strength without reaching overbought levels, indicating there is still room for further gains. These technical indicators indicate a positive trend, suggesting that the FTSE 100 is poised for further growth. As such, the index remains an appealing option for short-term investors seeking potential opportunities. On the weekly chart, the FTSE 100 gained 2.02%, closing at 8,673.96. The index remains well above the 50-period SMA at 8,186.40, with support at 8,277. Resistance is at 8,700, and a breakout above this level could push the index toward 8,800. However, a drop below 8,020 could signal downside risk. Investors should monitor these levels for insight into future price movements. 

A screenshot of a computer screen

Description automatically generated

Data Source - Refinitiv 


Disclaimer- This article has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine. Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate to your objectives, financial situation and needs before acting upon it. There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product. Please note past performance is neither an indicator nor a guarantee of future performance. You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice/information in this article or on the Kalkine website. Not all investments are appropriate for all people. The information in this article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its articles, newsletters and websites. All information represents our views at the date of publication and may change without notice. Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this article, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law. Please also read our Terms & Conditions and Financial Services Guide for further information. On the date of publishing this article (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures. Some of the images/music that may be used in the article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the article unless stated otherwise. The images/music that may be used in the article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary. Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions